Literature DB >> 25011975

PET imaging of cardiac wound healing using a novel [68Ga]-labeled NGR probe in rat myocardial infarction.

Jochen Tillmanns1, Magdalena Schneider, Daniela Fraccarollo, Jan-Dieter Schmitto, Florian Länger, Dominik Richter, Johann Bauersachs, Samuel Samnick.   

Abstract

PURPOSE: Peptides containing the asparagine-glycine-arginine (NGR) motif bind to aminopeptidase N (CD13), which is expressed on inflammatory cells, endothelial cells, and fibroblasts. It is unclear whether radiolabeled NGR-containing tracers could be used for in vivo imaging of the early wound-healing phase after myocardial infarction (MI) using positron emission tomography (PET). PROCEDURES: Uptake of novel tracer [(68)Ga]NGR was assessed together with [(68)Ga]arginine-glycine-aspartic acid ([(68)Ga]RGD) and 2-deoxy-2-[(18) F]fluoro-D-glucose after myocardial ischemia/reperfusion (MI/R) injury using μ-PET and autoradiography, and relative expressions of CD13 and integrin β3 were assessed in fibroblasts, inflammatory cells, and endothelial cells by immunohistochemistry.
RESULTS: In the infarcted myocardium, uptake of [(68)Ga]NGR was maximal from days 3 to 7 after MI/R, and correlated with fibroblast and inflammatory cell infiltration as well as [(68)Ga]RGD uptake.
CONCLUSIONS: [(68)Ga]NGR allows noninvasive and sequential determination of CD13 expression in fibroblasts and inflammatory cells by PET. This will facilitate monitoring of CD13 in the individual wound healing processes, allowing patient-specific therapies to improve outcome after MI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25011975     DOI: 10.1007/s11307-014-0751-2

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  43 in total

1.  Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats.

Authors:  Hossam M Sherif; Antti Saraste; Stephan G Nekolla; Eliane Weidl; Sybille Reder; Arne Tapfer; Martina Rudelius; Takahiro Higuchi; René M Botnar; Hans-Jürgen Wester; Markus Schwaiger
Journal:  J Nucl Med       Date:  2012-02       Impact factor: 10.057

2.  In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction.

Authors:  Marcus R Makowski; Ullrich Ebersberger; Stephan Nekolla; Markus Schwaiger
Journal:  Eur Heart J       Date:  2008-03-27       Impact factor: 29.983

3.  Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.

Authors:  Johannes Notni; Karolin Pohle; Hans-Jürgen Wester
Journal:  Nucl Med Biol       Date:  2012-09-18       Impact factor: 2.408

4.  Integrin-targeted imaging of inflammation in vascular remodeling.

Authors:  Mahmoud Razavian; Ravi Marfatia; Heloise Mongue-Din; Sina Tavakoli; Albert J Sinusas; Jiasheng Zhang; Lei Nie; Mehran M Sadeghi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

5.  Experimental myocardial infarction of the rat and stimulation of the revascularization by the flavonoid drug crataemon.

Authors:  Z Guendjev
Journal:  Arzneimittelforschung       Date:  1977

6.  Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.

Authors:  Flavio Curnis; Gianluigi Arrigoni; Angelina Sacchi; Lucia Fischetti; Wadih Arap; Renata Pasqualini; Angelo Corti
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

7.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Authors:  David F Meoli; Mehran M Sadeghi; Svetlana Krassilnikova; Brian N Bourke; Frank J Giordano; Donald P Dione; Haili Su; D Scott Edwards; Shuang Liu; Thomas D Harris; Joseph A Madri; Barry L Zaret; Albert J Sinusas
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.

Authors:  Luca Menichetti; Claudia Kusmic; Daniele Panetta; Daniela Arosio; Debora Petroni; Marco Matteucci; Piero A Salvadori; Cesare Casagrande; Antonio L'Abbate; Leonardo Manzoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-15       Impact factor: 9.236

9.  Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.

Authors:  Kai Chen; Wenhui Ma; Guoquan Li; Jing Wang; Weidong Yang; Li-Peng Yap; Lindsey D Hughes; Ryan Park; Peter S Conti
Journal:  Mol Pharm       Date:  2012-12-13       Impact factor: 4.939

10.  Inhibitory effect of anti-aminopeptidase N/CD13 antibodies on fibroblast migration.

Authors:  Amy Lai; Abdi Ghaffari; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2010-06-30       Impact factor: 3.396

View more
  3 in total

Review 1.  Emerging Tracers for Nuclear Cardiac PET Imaging.

Authors:  Dong-Yeon Kim; Sang-Geon Cho; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2018-05-08

Review 2.  Molecular Imaging of Aminopeptidase N in Cancer and Angiogenesis.

Authors:  Cynthia L Schreiber; Bradley D Smith
Journal:  Contrast Media Mol Imaging       Date:  2018-06-25       Impact factor: 3.161

Review 3.  Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy.

Authors:  Liqin Zhu; Zhikai Ding; Xingliang Li; Hongyuan Wei; Yue Chen
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.